Recent Updates
Recently added Catalysts
CLNN Positive Sentiment Score: 70/100

Clene Nanomedicine Announces Participation in Renmark Virtual Non-Deal Roadshow Series on January 18 and January 23

Key Takeaway: Clene Inc. (CLNN) has announced its participation in the Renmark Virtual Non-Deal Roadshow Series taking place on January 18 and January 23. The company encourages stakeholders and investors to register for the free live events, during which the CEO and CFO will provide updates on company developments followed by a Q&A session. Registration is limited, but replays will be available on Clene's Investor website shortly after the events. This engagement aims to strengthen investor relations and provide important insights into the company's future operations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in virtual non-deal roadshows can enhance stakeholder engagement.
  • Opportunity for CEO and CFO to present the latest developments.
  • Events are free, promoting greater accessibility for interested parties.

Full Press Release Details

SALT LAKE CITY, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company today announced that it will participate in Renmark Financial Communications Inc.’s Virtual Non-Deal Roadshow Series on January 18 and January 23. The Company welcomes stakeholders, investors, and other interested parties to register and attend these free live events.
Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will deliver the latest investor presentation followed by a live Q&A session. Individuals can register by using the link below. As a reminder, registration for the live events may be limited but access to the replays will be posted to the Company’s Investor website within a few days of the events.
REGISTER HERE AND EVENT DETAILS:
To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the “safe harbor” provisions created by those laws. Clene’s forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding our future operations. In addition, any statements that refer to future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements represent our views as of the date of this document and involve a number of judgments, risks and uncertainties. We anticipate that subsequent events and developments will cause our views to change. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date.
Renmark Financial Communications Inc.
Tel.: (416) 644-2020 or (212) 812-7680

Frequently Asked Questions

When is Clene's virtual non-deal roadshow scheduled?

Clene's virtual non-deal roadshow is on January 18 and January 23, 2023.

Who will present at the Clene events?

Rob Etherington, CEO, and Morgan Brown, CFO, will deliver the presentation.

How can I register for the Clene virtual events?

Interested individuals can register via the provided links in the announcement.

Will event replays be available?

Yes, replays will be posted on Clene’s Investor website shortly after the events.

What browser is recommended for the events?

Access the links using the latest version of Google Chrome for optimal connectivity.

Last updated: Jan 11, 2023